From: Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling
Model term | Method | p (Wald) | OR | 95% CI |
---|---|---|---|---|
Uni-variable models withp<0.05 | ||||
PD-L1 | IHC | 0.0025 | 2.7 | 1.7 — 4.8 |
EGFR | CNA | 0.0069 | 0.14 | 0.03 — 0.54 |
NF1 | NGS | 0.015 | 2.9 | 1.4 — 6.0 |
PD-1 | IHC | 0.017 | 3.1 | 2.2 — 5.5 |
NTRK1 | F-RNA | 0.022 | 27 | 2.0 — 507 |
LYL1 | CNA | 0.022 | 26 | 1.9 — 498 |
IDH2 | NGS | 0.026 | 24 | 1.8 — 465 |
PTCH1 | NGS | 0.026 | 24 | 1.3 — 159 |
EGFRvIII | FFA | 0.04 | 0.22 | 0.06 — 0.95 |
Best two-variable model | ||||
Intercept |  | <0.001 | 0.04 | 0.01 — 0.15 |
EGFR | CNA | 0.084 | 0.26 | 0.06 — 1.1 |
PD-1 | IHC | 0.072 | 4.1 | 1.0 — 17.3 |